Mustang Bio 3Q 2026: Net loss ($964K) — 10-Q Summary

Mustang Bio's net loss widened year over year in the third quarter, as research and development expense rose following nonrecurring savings from settling aged payables in the prior-year quarter. Lower general and administrative expense partly offset the increase, while interest income declined.Fina…